SAN FRANCISCO, Feb. 14, 2025 ( GLOBE NEWSWIRE ) -- BioAge Labs BIOA, a biopharmaceutical company focused on metabolic diseases, is facing a class-action lawsuit from shareholders who allege the company misled investors about the safety and prospects of a key drug candidate before its initial ...

A new SEC filing reveals that Scott J Kinney, Vice President at Avista AVA, made a notable insider purchase on February 13,. What Happened: In a significant move reported in a Form 4 filing with the U.S.

A significant insider buy by Latisha D. Hill, Vice President at Avista AVA, was executed on February 13, and reported in the recent SEC filing. What Happened: Hill's recent purchase of 5,882 shares of Avista, disclosed in a Form 4 filing with the U.S.

Disclosed in the latest SEC filing, a significant insider purchase on February 13, involves Joshua D DiLuciano, Vice President at Avista AVA. What Happened: In a significant move reported in a Form 4 filing with the U.S.

Roopa Unnikrishnan, SVP at IDEX IEX, reported an insider buy on February 13, according to a new SEC filing. What Happened: In a significant move reported in a Form 4 filing with the U.S. Securities and Exchange Commission on Thursday, Unnikrishnan purchased 657 shares of IDEX, demonstrating ...

It was revealed in a recent SEC filing that Melissa S Flores, SVP at IDEX IEX made a noteworthy insider purchase on February 13,. What Happened: In a significant move reported in a Form 4 filing with the U.S.

Megan Clarken, Chief Executive Officer at Criteo CRTO, executed a substantial insider sell on February 13, according to an SEC filing. What Happened: According to a Form 4 filing with the U.S. Securities and Exchange Commission on Thursday, Clarken sold 21,304 shares of Criteo.

Making a noteworthy insider sell on February 13, Donald J Klunk, Chief Accounting Officer at Genpact G, is reported in the latest SEC filing. What Happened: According to a Form 4 filing with the U.S. Securities and Exchange Commission on Thursday, Klunk sold 4,136 shares of Genpact.

GLENVIEW, Ill., Feb. 14, 2025 ( GLOBE NEWSWIRE ) -- The Board of Directors of Illinois Tool Works Inc. ( NYSE: ITW ) declared a dividend on the company's common stock of $1.50 per share for the first quarter of 2025. The dividend equates to $6.00 per share on a full-year basis.

Cannabis stocks trade at 5.49x EBITDA, showing no belief in federal rescheduling or tax relief. Florida & Texas adult-use potential may be MSOs' only growth hope, per Viridian analysis. Get two weeks of free access to pro-level trading tools, including news alerts, scanners, and real-time market ...